 LOS ANGELES--BUSINESS WIRE--ChromaDex Corp. NASDAQ:CDXC issued the following statement: ChromaDex announced today plans to appeal a September 14 decision granting a Motion for Summary Judgment MSJ in its lawsuit for patent infringement against Elysium Health, Inc. Elysium in the United States District Court for the District of Delaware. ChromaDex licenses U.S. Patent No. 8,383,086 the 086 patent and U.S. Patent No. 8,197,807 the 807 patent from the Trustees of Dartmouth Coll 